Literature DB >> 26048625

The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis.

Nicola Pappone1, Matteo Nicola Dario Di Minno2, Salvatore Iervolino3, Roberta Lupoli2, Reuven Mader4, Carmela Zincarelli1, Rosario Peluso2.   

Abstract

Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by ossification of different entheses. Psoriatic arthritis (PsA) is a seronegative spondyloarthritis associated with psoriasis. Given the possible overlap of the two diseases, we assessed whether DISH presence may affect PsA clinical outcomes. Also, predictors of DISH presence in the cohort were investigated. Consecutive PsA patients from two Italian Rheumatology Research Units were enrolled. Subjects were splitted into two groups, according to the current treatment (TNF-α blockers or traditional DMARDs). All patients underwent a rheumatologic examination, blood sample collections and spine radiographs. Information about traditional vascular risk factors was recorded. In each patient, the presence of minimal disease activity was evaluated and the presence of DISH was established according to the Resnick and Niwayama criteria. Among the 80 enrolled subjects (57.5 % men, mean age 56.5 ± 11.1 years), the overall prevalence of DISH was 30.0 %. Patients with DISH were older, with higher BMI and waist circumference. DISH subjects showed worsen BASMI, HAQ and ESR. In a multivariate regression model, BASMI was a significant predictor of DISH presence (OR 3.027, 95 % CI 1.449-6.325, p = 0.003). The prevalence of MDA was lower in DISH patients than in no-DISH (16.7 vs 41.1 %, p = 0.041), and the presence of DISH was a predictor of not achieving MDA (OR 3.485, 95 % CI 1.051-11.550, p = 0.041). PsA subjects with DISH showed worsen indices of spine mobility and articular function and lower prevalence of minimal disease activity than no-DISH patients.

Entities:  

Keywords:  Diffuse idiopathic skeletal hyperostosis; Minimal disease activity; Psoriatic arthritis

Mesh:

Substances:

Year:  2015        PMID: 26048625     DOI: 10.1007/s00296-015-3303-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Carlo Palazzi; Angela Padula; Reuven Mader; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

2.  Concomitant ankylosing spondylitis and DISH.

Authors:  I Olivieri; C Vitali; G Gemignani; G Pasero
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

3.  Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.

Authors:  Salvatore Iervolino; Matteo Nicola Dario Di Minno; Rosario Peluso; Mariana Lofrano; Anna Russolillo; Giovanni Di Minno; Raffaele Scarpa
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

4.  Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one.

Authors:  Reuven Mader; Dan Buskila; Jorrit-Jan Verlaan; Fabiola Atzeni; Ignazio Olivieri; Nicola Pappone; Carlo Di Girolamo; Piercarlo Sarzi-Puttini
Journal:  Rheumatology (Oxford)       Date:  2012-09-29       Impact factor: 7.580

Review 5.  Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.

Authors:  Matteo Nicola Dario Di Minno; Salvatore Iervolino; Roberta Lupoli; Anna Russolillo; Antonio Coppola; Rosario Peluso; Raffaele Scarpa; Giovanni Di Minno
Journal:  Semin Thromb Hemost       Date:  2012-03-07       Impact factor: 4.180

6.  Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism.

Authors:  M N D Di Minno; A Tufano; A Guida; M Di Capua; A M De Gregorio; A M Cerbone; G Tarantino; G Di Minno
Journal:  Thromb Res       Date:  2011-01-13       Impact factor: 3.944

7.  Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs.

Authors:  Matteo Nicola Dario Di Minno; Salvatore Iervolino; Rosario Peluso; Raffaele Scarpa; Giovanni Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-06       Impact factor: 8.311

8.  Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes.

Authors:  X Baraliakos; J Listing; M Rudwaleit; H Haibel; J Brandt; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

9.  Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis.

Authors:  Amir Haddad; Arane Thavaneswaran; Sergio Toloza; Vinod Chandran; Dafna D Gladman
Journal:  J Rheumatol       Date:  2013-06-15       Impact factor: 4.666

Review 10.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.